Evaluation of Efficacy and Safety of Different Doses of Eladis® in the Therapy of Cough Against Acute Respiratory Viral Infection

Evaluation of Efficacy and Safety of Different Doses of Eladis® in the Therapy of Cough Against Acute Respiratory Viral Infection

Aim. Justification of the optimal dosage regimen regarding the efficacy and safety of Eladis®, film-coated tablets, 10 mg (Valenta Pharm JSC, Russia) in comparison with placebo in patients with non-productive cough due to acute respiratory viral infection (ARVI). Material and methods. A double-blind pla...

Full description

Saved in:
Bibliographic Details
Main Authors: E. D. Volnaya, S. V. Teplykh, V. V. Popova, O. A. Vasilevskaya, E. A. Polyakova, S. E. Ushakova, V. B. Shunkov, A. A. Globenko, A. V. Kapashin, M. A. Pasko
Format: Article
Language:Russian
Published: LLC "Publishing House OKI" 2024-10-01
Series:Антибиотики и Химиотерапия
Subjects:
cough
acute respiratory viral infections
eladis®
Online Access:https://www.antibiotics-chemotherapy.ru/jour/article/view/1144
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.antibiotics-chemotherapy.ru/jour/article/view/1144

Similar Items